R. Espada

499 total citations
8 papers, 437 citations indexed

About

R. Espada is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, R. Espada has authored 8 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Public Health, Environmental and Occupational Health and 3 papers in Epidemiology. Recurrent topics in R. Espada's work include Antifungal resistance and susceptibility (6 papers), Research on Leishmaniasis Studies (5 papers) and Parasitic Diseases Research and Treatment (3 papers). R. Espada is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Research on Leishmaniasis Studies (5 papers) and Parasitic Diseases Research and Treatment (3 papers). R. Espada collaborates with scholars based in Spain. R. Espada's co-authors include Juan J. Torrado, M. Paloma Ballesteros, Santiago Torrado, Germán Rivas, Carlos Alfonso, Gloria Molero, José María Alunda, F. Bolás‐Fernández, Josep Guarro and Francisco Pastor and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Journal of Antimicrobial Chemotherapy.

In The Last Decade

R. Espada

8 papers receiving 428 citations

Peers

R. Espada

ID

PS

PHEOH

EPIDE

MB

Katie Amssoms Belgium

Calvin J. Chany United States

Els W. M. van Etten Netherlands

Harinder Singh India

Sixiang Sai China

Jennifer J. Peters United States

Ghaith Aljayyoussi United Kingdom

Shalini Asthana India

Paula Renata Lima Machado Brazil

Kléber Juvenal Silva Farias Brazil

Katie Amssoms Belgium

R. Espada

93 ×0.6

ID

81 ×0.6

PS

78 ×0.6

PHEOH

88 ×0.9

EPIDE

112 ×1.2

MB

Citations per year, relative to R. Espada R. Espada (= 1×) peers Katie Amssoms

Countries citing papers authored by R. Espada

Since Specialization

Citations

This map shows the geographic impact of R. Espada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Espada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Espada more than expected).

Fields of papers citing papers by R. Espada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Espada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Espada. The network helps show where R. Espada may publish in the future.

Co-authorship network of co-authors of R. Espada

This figure shows the co-authorship network connecting the top 25 collaborators of R. Espada. A scholar is included among the top collaborators of R. Espada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Espada. R. Espada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Espada, R., et al.. (2011). Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres. Journal of Microencapsulation. 28(8). 791–798. 9 indexed citations

2.

Mariné, Marçal, R. Espada, Juan J. Torrado, Francisco Pastor, & Josep Guarro. (2009). Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis. International Journal of Antimicrobial Agents. 34(6). 566–569. 4 indexed citations

3.

Espada, R., et al.. (2008). Efficacy of alternative dosing regimens of poly-aggregated amphotericin B. International Journal of Antimicrobial Agents. 32(1). 55–61. 8 indexed citations

4.

Espada, R., et al.. (2008). In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation. Journal of Antimicrobial Chemotherapy. 61(5). 1125–1131. 24 indexed citations

5.

Espada, R., et al.. (2008). Effect of aggregation state on the toxicity of different amphotericin B preparations. International Journal of Pharmaceutics. 361(1-2). 64–69. 99 indexed citations

6.

Marine, Megan B., R. Espada, Juan J. Torrado, Francisco Pastor, & Josep Guarro. (2008). Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata. Journal of Antimicrobial Chemotherapy. 61(4). 880–883. 7 indexed citations

7.

Torrado, Juan J., R. Espada, M. Paloma Ballesteros, & Santiago Torrado. (2007). Amphotericin B Formulations and Drug Targeting. Journal of Pharmaceutical Sciences. 97(7). 2405–2425. 249 indexed citations

8.

Espada, R., et al.. (2007). HPLC assay for determination of amphotericin B in biological samples. Biomedical Chromatography. 22(4). 402–407. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact